So if I’m understanding correctly your line of thinking is he’s just following his former colleagues? Despite having extensive knowledge of Bisantrenes lack of cardio toxicity and helping champion the Triangle report. We all saw the numbers.
it just seems strange to me that you would sell out for so much less, all because you’ve got a disagreement on strategy? Or does he foresee the risk with RC220 too great? Doesnt make much sense.
RAC - Charts & Price Action, page-19128
-
- There are more pages in this discussion • 2,495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.86 |
Change
-0.015(0.80%) |
Mkt cap ! $316.8M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.88 | $1.79 | $163.0K | 89.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34299 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.86 | 3635 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |